These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 6018366)
1. Immune inhibition of urea breakdown in patients with cirrhosis. Thomson A; Holmes AW Gastroenterology; 1967 Jan; 52(1):14-7. PubMed ID: 6018366 [No Abstract] [Full Text] [Related]
2. Regulation of urea synthesis by diet protein and carbohydrate in normal man and in patients with cirrhosis. Relationship to glucagon and insulin. Hamberg O Dan Med Bull; 1997 Jun; 44(3):225-41. PubMed ID: 9233544 [TBL] [Abstract][Full Text] [Related]
3. Immune inhibition of urea breakdown in cirrhosis of the liver. Nutr Rev; 1967 Jul; 25(7):201-3. PubMed ID: 6047057 [No Abstract] [Full Text] [Related]
4. [Controlled protein administration diet and the prevention of hepatic encephalopathy]. Strata A; Giuberti T; Magnati G; Regolisti M; Sacchini D; Fiaccadori F Minerva Dietol Gastroenterol; 1984; 30(3):245-50. PubMed ID: 6504373 [No Abstract] [Full Text] [Related]
6. [Problems of protein supply in patients with liver cirrhosis]. Leimenstoll G; Leimenstoll A; Moch KJ; Kamenich W; Matthes KJ Med Welt; 1982 Sep; 33(35):1195-7. PubMed ID: 6127593 [No Abstract] [Full Text] [Related]
7. Zinc supplementation and amino acid-nitrogen metabolism in patients with advanced cirrhosis. Marchesini G; Fabbri A; Bianchi G; Brizi M; Zoli M Hepatology; 1996 May; 23(5):1084-92. PubMed ID: 8621138 [TBL] [Abstract][Full Text] [Related]
8. Brain metabolism of 13N-ammonia during acute hepatic encephalopathy in cirrhosis measured by positron emission tomography. Keiding S; Sørensen M; Bender D; Munk OL; Ott P; Vilstrup H Hepatology; 2006 Jan; 43(1):42-50. PubMed ID: 16374868 [TBL] [Abstract][Full Text] [Related]
9. Ammonia metabolism in the gut. Summerskill WH; Wolpert E Am J Clin Nutr; 1970 May; 23(5):633-9. PubMed ID: 5444997 [No Abstract] [Full Text] [Related]
10. Gastrointestinal urease in man. II. Urea hydrolysis and ammonia absorption in upper and lower gut lumen and the effect of neomycin. Evans WB; Aoyagi T; Summerskill WH Gut; 1966 Dec; 7(6):635-9. PubMed ID: 5957515 [No Abstract] [Full Text] [Related]
11. [Effects of diets of different protein and isonitrogenous composition, on the arterial ammonia of patients with cirrhosis]. Sanhueza P; Barahona E; Rios E; Navia E; Orrego H Rev Med Chil; 1967 Feb; 95(2):77-82. PubMed ID: 5601305 [No Abstract] [Full Text] [Related]
13. Management of hepatic encephalopathy in patients with cirrhosis. Wright G; Jalan R Best Pract Res Clin Gastroenterol; 2007; 21(1):95-110. PubMed ID: 17223499 [TBL] [Abstract][Full Text] [Related]
14. [Basics of nutrition in cirrhosis of the liver]. Mörk H MMW Fortschr Med; 2007 Apr; 149(17):33-4. PubMed ID: 17674907 [TBL] [Abstract][Full Text] [Related]
15. Gastrointestinal transit in cirrhotic patients: effect of hepatic encephalopathy and its treatment. Van Thiel DH; Fagiuoli S; Wright HI; Chien MC; Gavaler JS Hepatology; 1994 Jan; 19(1):67-71. PubMed ID: 8276369 [TBL] [Abstract][Full Text] [Related]
16. Intestinal bacteria and protein metabolism in human liver cirrhosis. Muting D; Reikowski H; Arfeen N Am J Proctol; 1975 Oct; 26(5):41-50. PubMed ID: 1163650 [No Abstract] [Full Text] [Related]
18. [Hyperammonemia and hepatic encephalopathy in cirrhotics receiving spironolactone (author's transl)]. Imler M; Schlienger JL Nouv Presse Med; 1977 Nov; 6(37):3407-10. PubMed ID: 600713 [TBL] [Abstract][Full Text] [Related]
19. The distribution of ammonium nitrogen in venous blood, ascites, and cerebrospinal fluid in cases of hepatic cirrhosis. Ciplea A; Baltă N; Stancu C; Drăgulescu N Rev Roum Physiol; 1970; 7(2):163-70. PubMed ID: 5492066 [No Abstract] [Full Text] [Related]